Pain Management · Anesthesia
Positive results could lead to a shift in clinical guidelines favoring SPSIPB, affecting market dynamics for anesthetic techniques and opioid alternatives.
Multi-agent research across ingested FDA, EMA, MHRA, PMDA, PubMed, ClinicalTrials.gov, company documents, and Humanexa signals.
Last run 6/5/2026, 1:54:27 PM
Assessment confidence: 74% · The main uncertainty is whether clinical benefit translates into regulatory momentum and guideline influence.
Positive results could lead to a shift in clinical guidelines favoring SPSIPB, affecting market dynamics for anesthetic techniques and opioid alternatives. Assessment grounded in 3 ranked evidence items (2 high-relevance).
Positive results could lead to a shift in clinical guidelines favoring SPSIPB, affecting market dynamics for anesthetic techniques and opioid alternatives. The strongest clinical anchor is Postoperative Opioid Consumption of Serratus Posterior Superior Intercostal Plane Block Versus Thoracic Paravertebral Block (ClinicalTrials.gov), sub-indication match (pain).
The most relevant competitive pressure comes from The findings may influence anesthesia practices and opioid-sparing strategies in surgical settings, potentially impacting the adoption of SPSIPB over traditional methods..
Regulatory outlook for Comparative Study of SPSIPB vs Thoracic Paravertebral Block for Opioid Reduction is limited by sparse ingested precedent data.
No evidence in this category.
Postoperative Opioid Consumption of Serratus Posterior Superior Intercostal Plane Block Versus Thoracic Paravertebral Block
ClinicalTrials.govhigh relevance
Sub-indication match (pain)
FDA document
View sourceEXORA vs ESP Blocks in Laparoscopic Cholecystectomy
ClinicalTrials.govhigh relevance
Sub-indication match (pain)
FDA document
View sourceVirtual Reality Based High-intensity Interval Training in Chronic Low Back Pain
ClinicalTrials.govmedium relevance
Sub-indication match (pain)
FDA document
View sourceNutrition Intervention Trials in Linxian Follow-up Study
ClinicalTrials.govlow relevance
Weak alignment to signal sub-indication and entities
FDA document
View sourcePULSed Field Ablation for Atrial Fibrillation Using Balloon for Early Intervention - Study
ClinicalTrials.govlow relevance
Weak alignment to signal sub-indication and entities
FDA document
View sourceProspective Remapping With Concomitant Left Atrial Appendage Occlusion to Ensure Durable Electroporation Study
ClinicalTrials.govlow relevance
Weak alignment to signal sub-indication and entities
FDA document
View sourceNociception Level Index After Brachial Plexus Block In Upper Extremity Surgery
ClinicalTrials.govlow relevance
Weak alignment to signal sub-indication and entities
FDA document
View sourceHormones, Outcomes, and Pain Pathways in Exercise Study
ClinicalTrials.govlow relevance
Weak alignment to signal sub-indication and entities
FDA document
View sourcePilot Study on Geniculate Artery Embolization for Knee Osteoarthritis Initiated
Humanexa Signalslow relevance
Weak alignment to signal sub-indication and entities
Effects of fecal microbiota transplantation and probiotics on the gut microbiome in antibiotic-treated septic patients: A pilot randomized controlled trial.
PubMedlow relevance
Weak alignment to signal sub-indication and entities
FDA document
View sourceRBM15B-mediated m6A modification of FOXM1 activates the AURKA/TPX2 axis to promote epithelial-mesenchymal transition-driven endometrial cancer progression.
PubMedlow relevance
Weak alignment to signal sub-indication and entities
FDA document
View sourceCost-effectiveness analysis of apixaban compared with other oral anticoagulants for the treatment of non-valvular atrial fibrillation in Belgian healthcare setting.
PubMedlow relevance
Weak alignment to signal sub-indication and entities
FDA document
View sourceEffects of acute HMB-FA supplementation on antioxidant status and muscle damage in Elite Judoka: a randomized pilot trial.
PubMedlow relevance
Weak alignment to signal sub-indication and entities
FDA document
View sourcePrecedents · guidance
Loading regulatory precedents…
View full regulatory analysisCompetitors · threats
Loading competitive findings…
View full competitive analysisPositive results could lead to a shift in clinical guidelines favoring SPSIPB, affecting market dynamics for anesthetic techniques and opioid alternatives.
The findings may influence anesthesia practices and opioid-sparing strategies in surgical settings, potentially impacting the adoption of SPSIPB over traditional methods.
Monitor the trial results for differences in opioid consumption and respiratory outcomes, as well as subsequent adoption in clinical practice.
Monitor the trial results for differences in opioid consumption and respiratory outcomes, as well as subsequent adoption in clinical practice.
Track for follow-up milestones; no immediate action required.